TITLE

PROLIGO DEBUTS TRUESNP PRIMER KITS BASED ON LNA

PUB. DATE
April 2002
SOURCE
Worldwide Biotech;Apr2002, Vol. 14 Issue 4, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Introduces the TrueSNP primer kits based on Locked Nucleic Acids designed to genotype single nucleotide polymorphism, from Proligo LLC.
ACCESSION #
6419783

 

Related Articles

  • Proligo Ups Oligonucleotides Production Capacity.  // Chemical Market Reporter;1/20/2003, Vol. 263 Issue 3, p3 

    Reports that Proligo LLC will expand its production capacity for oligonucleotides in the U.S. and Japan. Increase demand for oligonucleotides; Construction of a state-of-the-art facility in Colorado; Other manufacturing sites of Proligo.

  • Degussa's Proligo Buys Genset's Oligonucleotides Biz.  // Chemical Market Reporter;2/25/2002, Vol. 261 Issue 8, p3 

    Reports on the acquisition of the oligonucleotides division of Genset SA by Proligo LLC. Estimate on the value of the acquisition; Purpose of the acquisition; Terms under the agreement.

  • Degussa Moves Into Large Oligonucleotides. Boswell, Clay // Chemical Market Reporter;10/7/2002, Vol. 262 Issue 12, p3 

    Reports that Degussa AG' fine chemicals business unit will combine the oligonucleotide business line of Proligo LLC with the cGMP custom manufacturing operations of Raylo Chemicals as of November 1, 2002. Focus of unit in providing consumables for the processing of genetic information;...

  • Nucleic Acids Manufacturers Prepare to Fuel the Genomic Revolution. Jarvis, Lisa // Chemical Market Reporter;9/10/2001, Vol. 260 Issue 10, p8 

    Reports on the preparation of nucleic acid manufacturers to supply the building blocks for the processing of genetic information. Estimated value of nucleic acids; Plan of Degussa Corp. to invest in Proligo's manufacturing sites; Effort made by Avecia for the genomics revolution and in serving...

  • Degussa Unites Oligonucleotides in Push for 'Genetic Medicines'. Schmitt, Bill // Chemical Week;10/9/2002, Vol. 164 Issue 40, p26 

    Reports the integration of the fine chemicals business of Degussa and the oligonucleotide business of Proligo with the cyclic guanylic acid custom manufacturing operation of Raylo Chemicals company in October 2002. Popularity of oligonucleotides among biopharmaceutical companies; Business...

  • Degussa Moves Into Genomics By Taking Control of Proligo.  // Chemical Market Reporter;9/3/2001, Vol. 260 Issue 9, p6 

    Reports that Degussa AG is taking over full control of Proligo LLC, which produces nucleic acids at plants in Hamburg, Germany and Boulder, Colorado. Degussa's investment to boost production at the two units; Amount of money that Degussa is paying Gilead Sciences for the purchase of its 49...

  • Sigma-Aldrich to buy Proligo. Cozier, Muriel // European Chemical News;2/21/2005, Vol. 82 Issue 2135, p21 

    Reports that Sigma-Aldrich has agreed to buy genomics research supplier Proligo Group from Germany-based Degussa. Background of the companies; Source of the funding for the purchase.

  • Sigma-Aldrich buys Degussa's Proligo unit.  // Chemical Business;Mar2005, Vol. 19 Issue 3, p84 

    Reports the acquisition of Degussa's Proligo subsidiary, a provider of nucleic acids and oligonucleotide synthesis, by Sigma-Aldrich in 2005. Sales posted by Proligo in 2004; Information on Proligo.

  • Contract Oligonucleotide Manufacturing. Papanikolaw, Jim // Chemical Market Reporter;01/18/99, Vol. 255 Issue 3, p16 

    Reports that the approval of Isis Pharmaceuticals' antisense Vitravene or fomivirsen sodium injectable in 1998 has helped to open the market for the supply of oligonucleotides. Details on antisense molecules; Business operations of two nucleotides manufacturers, Zeneca LifeScience Molecules...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics